Login to Your Account



Washington Roundup

CMS to Seek Payment Advice on ESAs in Kidney Patients

By Donna Young


Monday, August 24, 2009
WASHINGTON - The Centers for Medicare & Medicaid Services (CMS) plans to convene an advisory panel next March to provide input on establishing a national coverage decision (NCD) for the use of anemia drugs, such as Amgen Inc.'s Epogen (epoetin alfa) and Centocor Ortho Biotech Product LP's Procrit (epoetin alfa), in patients with chronic kidney disease (CKD). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription